The 20-hectare original campus of the Serum Institute of India (above) now abuts its equally large biotech park, which has vastly expanded the company’s vaccine production capabilities.
By Jon CohenReporting for this story was supported by the Pulitzer Center.PUNE, INDIA—In a world of have and have-nots, Adar Poonawalla is most decidedly a have, with both abundant personal wealth and a corner on what promises to be a massive supply of one of the world’s most desperately sought commodities: COVID-19 vaccines.
Affable but feisty and a fan of bespoke suits, the 40-year-old heads the Serum Institute of India, the world’s largest maker of vaccines.